177 related articles for article (PubMed ID: 20624223)
1. Biological and structural characterization of the Mycobacterium smegmatis nitroreductase NfnB, and its role in benzothiazinone resistance.
Manina G; Bellinzoni M; Pasca MR; Neres J; Milano A; Ribeiro AL; Buroni S; Skovierová H; Dianišková P; Mikušová K; Marák J; Makarov V; Giganti D; Haouz A; Lucarelli AP; Degiacomi G; Piazza A; Chiarelli LR; De Rossi E; Salina E; Cole ST; Alzari PM; Riccardi G
Mol Microbiol; 2010 Sep; 77(5):1172-85. PubMed ID: 20624223
[TBL] [Abstract][Full Text] [Related]
2. Analogous mechanisms of resistance to benzothiazinones and dinitrobenzamides in Mycobacterium smegmatis.
Ribeiro AL; Degiacomi G; Ewann F; Buroni S; Incandela ML; Chiarelli LR; Mori G; Kim J; Contreras-Dominguez M; Park YS; Han SJ; Brodin P; Valentini G; Rizzi M; Riccardi G; Pasca MR
PLoS One; 2011; 6(11):e26675. PubMed ID: 22069462
[TBL] [Abstract][Full Text] [Related]
3. Characterization of DprE1-Mediated Benzothiazinone Resistance in Mycobacterium tuberculosis.
Foo CS; Lechartier B; Kolly GS; Boy-Röttger S; Neres J; Rybniker J; Lupien A; Sala C; Piton J; Cole ST
Antimicrob Agents Chemother; 2016 Nov; 60(11):6451-6459. PubMed ID: 27527085
[TBL] [Abstract][Full Text] [Related]
4. Structural basis for benzothiazinone-mediated killing of Mycobacterium tuberculosis.
Neres J; Pojer F; Molteni E; Chiarelli LR; Dhar N; Boy-Röttger S; Buroni S; Fullam E; Degiacomi G; Lucarelli AP; Read RJ; Zanoni G; Edmondson DE; De Rossi E; Pasca MR; McKinney JD; Dyson PJ; Riccardi G; Mattevi A; Cole ST; Binda C
Sci Transl Med; 2012 Sep; 4(150):150ra121. PubMed ID: 22956199
[TBL] [Abstract][Full Text] [Related]
5. Decaprenylphosphoryl-β-D-ribose 2'-epimerase, the target of benzothiazinones and dinitrobenzamides, is an essential enzyme in Mycobacterium smegmatis.
Crellin PK; Brammananth R; Coppel RL
PLoS One; 2011 Feb; 6(2):e16869. PubMed ID: 21346818
[TBL] [Abstract][Full Text] [Related]
6. Benzothiazinones: prodrugs that covalently modify the decaprenylphosphoryl-β-D-ribose 2'-epimerase DprE1 of Mycobacterium tuberculosis.
Trefzer C; Rengifo-Gonzalez M; Hinner MJ; Schneider P; Makarov V; Cole ST; Johnsson K
J Am Chem Soc; 2010 Oct; 132(39):13663-5. PubMed ID: 20828197
[TBL] [Abstract][Full Text] [Related]
7. Nitazoxanide Analogs Require Nitroreduction for Antimicrobial Activity in Mycobacterium smegmatis.
Buchieri MV; Cimino M; Rebollo-Ramirez S; Beauvineau C; Cascioferro A; Favre-Rochex S; Helynck O; Naud-Martin D; Larrouy-Maumus G; Munier-Lehmann H; Gicquel B
J Med Chem; 2017 Sep; 60(17):7425-7433. PubMed ID: 28846409
[TBL] [Abstract][Full Text] [Related]
8. Clinical isolates of Mycobacterium tuberculosis in four European hospitals are uniformly susceptible to benzothiazinones.
Pasca MR; Degiacomi G; Ribeiro AL; Zara F; De Mori P; Heym B; Mirrione M; Brerra R; Pagani L; Pucillo L; Troupioti P; Makarov V; Cole ST; Riccardi G
Antimicrob Agents Chemother; 2010 Apr; 54(4):1616-8. PubMed ID: 20086151
[TBL] [Abstract][Full Text] [Related]
9. The 8-Pyrrole-Benzothiazinones Are Noncovalent Inhibitors of DprE1 from Mycobacterium tuberculosis.
Makarov V; Neres J; Hartkoorn RC; Ryabova OB; Kazakova E; Šarkan M; Huszár S; Piton J; Kolly GS; Vocat A; Conroy TM; Mikušová K; Cole ST
Antimicrob Agents Chemother; 2015 Aug; 59(8):4446-52. PubMed ID: 25987616
[TBL] [Abstract][Full Text] [Related]
10. Benzothiazinones are suicide inhibitors of mycobacterial decaprenylphosphoryl-β-D-ribofuranose 2'-oxidase DprE1.
Trefzer C; Škovierová H; Buroni S; Bobovská A; Nenci S; Molteni E; Pojer F; Pasca MR; Makarov V; Cole ST; Riccardi G; Mikušová K; Johnsson K
J Am Chem Soc; 2012 Jan; 134(2):912-5. PubMed ID: 22188377
[TBL] [Abstract][Full Text] [Related]
11. New Insight into Dearomatization and Decarbonylation of Antitubercular 4H-Benzo[e][1,3]thiazinones: Stable 5H- and 7H-Benzo[e][1,3]thiazines.
Richter A; Seidel RW; Graf J; Goddard R; Lehmann C; Schlegel T; Khater N; Imming P
ChemMedChem; 2022 Mar; 17(6):e202200021. PubMed ID: 35170242
[TBL] [Abstract][Full Text] [Related]
12. In vitro combination studies of benzothiazinone lead compound BTZ043 against Mycobacterium tuberculosis.
Lechartier B; Hartkoorn RC; Cole ST
Antimicrob Agents Chemother; 2012 Nov; 56(11):5790-3. PubMed ID: 22926573
[TBL] [Abstract][Full Text] [Related]
13. L-proline-catalysed facile green protocol for the synthesis and antimycobacterial evaluation of [1,4]-thiazines.
Indumathi S; Perumal S; Banerjee D; Yogeeswari P; Sriram D
Eur J Med Chem; 2009 Dec; 44(12):4978-84. PubMed ID: 19781824
[TBL] [Abstract][Full Text] [Related]
14. Crystal structure of reduced MsAcg, a putative nitroreductase from Mycobacterium smegmatis and a close homologue of Mycobacterium tuberculosis Acg.
Chauviac FX; Bommer M; Yan J; Parkin G; Daviter T; Lowden P; Raven EL; Thalassinos K; Keep NH
J Biol Chem; 2012 Dec; 287(53):44372-83. PubMed ID: 23148223
[TBL] [Abstract][Full Text] [Related]
15. Novel insight into the reaction of nitro, nitroso and hydroxylamino benzothiazinones and of benzoxacinones with Mycobacterium tuberculosis DprE1.
Richter A; Rudolph I; Möllmann U; Voigt K; Chung CW; Singh OMP; Rees M; Mendoza-Losana A; Bates R; Ballell L; Batt S; Veerapen N; Fütterer K; Besra G; Imming P; Argyrou A
Sci Rep; 2018 Sep; 8(1):13473. PubMed ID: 30194385
[TBL] [Abstract][Full Text] [Related]
16. Benzothiazinones kill Mycobacterium tuberculosis by blocking arabinan synthesis.
Makarov V; Manina G; Mikusova K; Möllmann U; Ryabova O; Saint-Joanis B; Dhar N; Pasca MR; Buroni S; Lucarelli AP; Milano A; De Rossi E; Belanova M; Bobovska A; Dianiskova P; Kordulakova J; Sala C; Fullam E; Schneider P; McKinney JD; Brodin P; Christophe T; Waddell S; Butcher P; Albrethsen J; Rosenkrands I; Brosch R; Nandi V; Bharath S; Gaonkar S; Shandil RK; Balasubramanian V; Balganesh T; Tyagi S; Grosset J; Riccardi G; Cole ST
Science; 2009 May; 324(5928):801-4. PubMed ID: 19299584
[TBL] [Abstract][Full Text] [Related]
17. Structure, dynamics, and interaction of Mycobacterium tuberculosis (Mtb) DprE1 and DprE2 examined by molecular modeling, simulation, and electrostatic studies.
Bhutani I; Loharch S; Gupta P; Madathil R; Parkesh R
PLoS One; 2015; 10(3):e0119771. PubMed ID: 25789990
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and evaluation of covalent inhibitors of DprE1 as antitubercular agents.
Liu L; Kong C; Fumagalli M; Savková K; Xu Y; Huszár S; Sammartino JC; Fan D; Chiarelli LR; Mikušová K; Sun Z; Qiao C
Eur J Med Chem; 2020 Dec; 208():112773. PubMed ID: 32898793
[TBL] [Abstract][Full Text] [Related]
19. Antimycobacterial activities of novel fluoroquinolones.
Senthilkumar P; Dinakaran M; Yogeeswari P; China A; Nagaraja V; Sriram D
Biomed Pharmacother; 2009 Jan; 63(1):27-35. PubMed ID: 18031974
[TBL] [Abstract][Full Text] [Related]
20. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]